The FDA has approved Novo Nordisk's Wegovy for treating a serious fatty liver disease, leading to a rise in the company's shares.

Editor’s Note: This approval is significant as it expands the use of Wegovy beyond weight management, potentially benefiting many patients with fatty liver disease and boosting Novo Nordisk's market position.

Gwen Orilio, diagnosed with stage-four lung cancer, defies the odds by surviving for ten years. Her story highlights advancements in cancer treatment and the changing perceptions of survival.

Editor’s Note: Gwen's journey is significant as it showcases the progress in cancer therapies that allow patients with severe diagnoses to live longer. Her experience inspires hope and emphasizes the importance of ongoing research in cancer treatment.

Some doctors and substance-abuse counselors caution that kratom may be addictive, while users claim it provides pain relief and mood enhancement. The herbal supplement is popular but raises concerns about health risks.

Ozempic and other GLP-1 weight-loss drugs are seen as potential solutions to obesity, but they face opposition from fat activists who question the framing of obesity as a problem.

Eli Lilly is negotiating to increase the price of its weight-loss drug Mounjaro in the U.K. for patients who pay out-of-pocket. This decision aligns with President Trump's aim to lower drug prices in the U.S.

Nike co-founder Phil Knight and his wife are donating a record $2 billion to Oregon Health & Science University. This significant gift comes at a time when public funding for higher education is being debated.

Silicon Valley parents are spending up to $50,000 on genetic testing to select embryos with higher IQs, aiming to raise exceptionally talented children.

More babies are being introduced to meat-heavy diets, munching on items like lamb and pork rinds. Experts are worried about the nutritional implications of this trend.

Bayer and Kumquat Biosciences have partnered on a promising new cancer drug, with Kumquat leading early trials and Bayer managing the market launch.